PCI Pharma Services operates across pharmaceutical development, manufacturing, clinical trial services, advanced drug delivery and packaging. The company maintains 38 facilities across North America, Canada, the UK, Ireland, Germany, Spain and Australia, employing over 8,500 people. With more than 50 years in the healthcare sector, it supports approximately 90 product launches annually.
The company's services span the full product lifecycle. Development services integrate quality controls from project inception to reduce time-to-market. Manufacturing capabilities support commercial deployment of therapies, while clinical trial services provide operational and related support. Advanced drug delivery technologies enable effective therapeutic administration, complemented by pharmaceutical packaging services as part of end-to-end commercialization.
PCI Pharma Services has committed to emissions reduction goals validated by the Science Based Targets initiative, aligning sustainability efforts with pharmaceutical innovation.
